EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Outcomes of endoscopic ultrasound-guided ablation and minimally invasive surgery in the treatment of pancreatic insulinoma: a systematic review and meta-analysis

Dan Xiao, Li Zhu, Si Xiong, Xu Yan, Qin Jiang, Ao Wang, Yegui Jia

Frontiers in Endocrinology · 2024

DOI: 10.3389/fendo.2024.1367068 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Endocrinology, 2024. Verfasst von Dan Xiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Insulinoma, Pancreatic Neoplasms, Minimally Invasive Surgical Procedures, Endosonography. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Most pancreatic insulinomas can be treated by minimally invasive modalities. The aim of this meta-analysis was to assess the clinical outcomes of endoscopic ultrasound (EUS)-guided ablation and minimally invasive surgery (MIS) in the treatment of pancreatic insulinoma. Materials and methods Online databases were searched for relevant studies. The primary aim was to compare the rates of adverse events (AEs) and the secondary aims were to compare the clinical and technical success rates, length of hospital stays, and symptom recurrence rates between EUS and MIS approaches.

Results

Eight studies with 150 patients were identified that reported EUS-guided ablation outcomes, forming the EUS group, and 9 studies with 236 patients reported MIS outcomes, forming the MIS group. The pooled median age of the included patients in the EUS group was greater than that of the MIS group (64.06 vs. 44.98 years old, p < 0.001). Also, the technical success rate was significantly higher in the EUS group (100% vs. 96.6%, p = 0.025), while the clinical success was significantly higher (6%) in the MIS group (94% vs. 98.7%, p = 0.021). The AE rates (18.7% vs. 31.1%, p = 0.012) and severe AE rates (1.3% vs. 7.9%, p = 0.011) were significantly lower in the EUS group. The median length of hospital stay in the EUS group (2.68 days, 95% CI: 1.88–3.48, I 2 = 60.3%) was significantly shorter than in the MIS group (7.40 days, 95% CI: 6.22–8.58, I 2 = 42.2%, p < 0.001). The recurrence rate was significantly higher in the EUS group (15.3% vs. 1.3%, p < 0.001).

Conclusions

EUS-guided ablation is associated with a lower AE rate and a shorter length of hospital stay, but a higher recurrence rate for the treatment of insulinoma compared with MIS. The EUS approach may be an alternative, even first-line, treatment for poor surgery candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinomaPancreatic NeoplasmsMinimally Invasive Surgical ProceduresEndosonographyHumansTreatment OutcomeLength of Stay

Stichwörter der Autor:innen

ablationadverse eventclinical outcomesendoscopic ultrasoundinsulinomaminimally invasive surgery

Autor:innen und Institutionen

  • Department of Gastroenterology, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, Hubei, China.
  • Gastrointestinal Surgery, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, Hubei, China.
  • Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China.
  • Internal Medicine Department, University Hospital, Wuhan Institute of Technology, Wuhan, Hubei, China.

Zitieren

APA

Xiao, D., Zhu, L., Xiong, S., Yan, X., Jiang, Q., Wang, A., & Jia, Y. (2024). Outcomes of endoscopic ultrasound-guided ablation and minimally invasive surgery in the treatment of pancreatic insulinoma: a systematic review and meta-analysis. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1367068

Vancouver

Xiao D, Zhu L, Xiong S, Yan X, Jiang Q, Wang A, et al. Outcomes of endoscopic ultrasound-guided ablation and minimally invasive surgery in the treatment of pancreatic insulinoma: a systematic review and meta-analysis. Frontiers in Endocrinology. 2024. doi:10.3389/fendo.2024.1367068

BibTeX
@article{Xiao2024,
  author = {Xiao, Dan and Zhu, Li and Xiong, Si and Yan, Xu and Jiang, Qin and Wang, Ao and Jia, Yegui},
  title = {Outcomes of endoscopic ultrasound-guided ablation and minimally invasive surgery in the treatment of pancreatic insulinoma: a systematic review and meta-analysis},
  journal = {Frontiers in Endocrinology},
  year = {2024},
  doi = {10.3389/fendo.2024.1367068}
}
Kostenlos starten →